TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Geographic Atrophy Treatment Market, Global Outlook and Forecast 2022-2028

Geographic Atrophy Treatment Market, Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 11 August 2022
  • Pages :65
  • Formats:
  • Report Code:SMR-7264979
OfferClick for best price

Best Price: $2600

Geographic Atrophy Treatment Market Size, Share 2022


Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.

This report contains market size and forecasts of Geographic Atrophy Treatment in Global, including the following market information:

Global Geographic Atrophy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Geographic Atrophy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Late-stage (Phase III) Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Geographic Atrophy Treatment include Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies and Roche Holding AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Geographic Atrophy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Geographic Atrophy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Geographic Atrophy Treatment Market Segment Percentages, by Type, 2021 (%)

Late-stage (Phase III) Treatment

Phase II Treatment

Phase I Treatment

Pre-Clinical Stage Treatment

Global Geographic Atrophy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Geographic Atrophy Treatment Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Global Geographic Atrophy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Geographic Atrophy Treatment Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Geographic Atrophy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Geographic Atrophy Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Hemera Biosciences

Allegro Ophthalmics

Stealth BioTherapeutics

Gyroscope Therapeutics

Regenerative Patch Technologies

Roche Holding AG

Gensight Biologics SA

NGM Biopharmaceuticals

AstraZeneca

Lineage Cell Therapeutics

Allergan

Report Attributes Report Details
Report Title Geographic Atrophy Treatment Market, Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 65 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Geographic Atrophy Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Geographic Atrophy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Geographic Atrophy Treatment Overall Market Size
2.1 Global Geographic Atrophy Treatment Market Size: 2021 VS 2028
2.2 Global Geographic Atrophy Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Geographic Atrophy Treatment Players in Global Market
3.2 Top Global Geographic Atrophy Treatment Companies Ranked by Revenue
3.3 Global Geographic Atrophy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Geographic Atrophy Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Geographic Atrophy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Geographic Atrophy Treatment Players in Global Market
3.6.1 List of Global Tier 1 Geographic Atrophy Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Geographic Atrophy Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Geographic Atrophy Treatment Market Size Markets, 2021 & 2028
4.1.2 Late-stage (Phase III) Treatment
4.1.3 Phase II Treatment
4.1.4 Phase I Treatment
4.1.5 Pre-Clinical Stage Treatment
4.2 By Type - Global Geographic Atrophy Treatment Revenue & Forecasts
4.2.1 By Type - Global Geographic Atrophy Treatment Revenue, 2017-2022
4.2.2 By Type - Global Geographic Atrophy Treatment Revenue, 2023-2028
4.2.3 By Type - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Geographic Atrophy Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Geographic Atrophy Treatment Revenue & Forecasts
5.2.1 By Application - Global Geographic Atrophy Treatment Revenue, 2017-2022
5.2.2 By Application - Global Geographic Atrophy Treatment Revenue, 2023-2028
5.2.3 By Application - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Geographic Atrophy Treatment Market Size, 2021 & 2028
6.2 By Region - Global Geographic Atrophy Treatment Revenue & Forecasts
6.2.1 By Region - Global Geographic Atrophy Treatment Revenue, 2017-2022
6.2.2 By Region - Global Geographic Atrophy Treatment Revenue, 2023-2028
6.2.3 By Region - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Geographic Atrophy Treatment Revenue, 2017-2028
6.3.2 US Geographic Atrophy Treatment Market Size, 2017-2028
6.3.3 Canada Geographic Atrophy Treatment Market Size, 2017-2028
6.3.4 Mexico Geographic Atrophy Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Geographic Atrophy Treatment Revenue, 2017-2028
6.4.2 Germany Geographic Atrophy Treatment Market Size, 2017-2028
6.4.3 France Geographic Atrophy Treatment Market Size, 2017-2028
6.4.4 U.K. Geographic Atrophy Treatment Market Size, 2017-2028
6.4.5 Italy Geographic Atrophy Treatment Market Size, 2017-2028
6.4.6 Russia Geographic Atrophy Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Geographic Atrophy Treatment Market Size, 2017-2028
6.4.8 Benelux Geographic Atrophy Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Geographic Atrophy Treatment Revenue, 2017-2028
6.5.2 China Geographic Atrophy Treatment Market Size, 2017-2028
6.5.3 Japan Geographic Atrophy Treatment Market Size, 2017-2028
6.5.4 South Korea Geographic Atrophy Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Geographic Atrophy Treatment Market Size, 2017-2028
6.5.6 India Geographic Atrophy Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Geographic Atrophy Treatment Revenue, 2017-2028
6.6.2 Brazil Geographic Atrophy Treatment Market Size, 2017-2028
6.6.3 Argentina Geographic Atrophy Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Geographic Atrophy Treatment Revenue, 2017-2028
6.7.2 Turkey Geographic Atrophy Treatment Market Size, 2017-2028
6.7.3 Israel Geographic Atrophy Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Geographic Atrophy Treatment Market Size, 2017-2028
6.7.5 UAE Geographic Atrophy Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Apellis Pharmaceuticals
7.1.1 Apellis Pharmaceuticals Corporate Summary
7.1.2 Apellis Pharmaceuticals Business Overview
7.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Major Product Offerings
7.1.4 Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.1.5 Apellis Pharmaceuticals Key News
7.2 IVERIC bio
7.2.1 IVERIC bio Corporate Summary
7.2.2 IVERIC bio Business Overview
7.2.3 IVERIC bio Geographic Atrophy Treatment Major Product Offerings
7.2.4 IVERIC bio Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.2.5 IVERIC bio Key News
7.3 Alkeus Pharmaceuticals
7.3.1 Alkeus Pharmaceuticals Corporate Summary
7.3.2 Alkeus Pharmaceuticals Business Overview
7.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Major Product Offerings
7.3.4 Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.3.5 Alkeus Pharmaceuticals Key News
7.4 Hemera Biosciences
7.4.1 Hemera Biosciences Corporate Summary
7.4.2 Hemera Biosciences Business Overview
7.4.3 Hemera Biosciences Geographic Atrophy Treatment Major Product Offerings
7.4.4 Hemera Biosciences Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.4.5 Hemera Biosciences Key News
7.5 Allegro Ophthalmics
7.5.1 Allegro Ophthalmics Corporate Summary
7.5.2 Allegro Ophthalmics Business Overview
7.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Major Product Offerings
7.5.4 Allegro Ophthalmics Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.5.5 Allegro Ophthalmics Key News
7.6 Stealth BioTherapeutics
7.6.1 Stealth BioTherapeutics Corporate Summary
7.6.2 Stealth BioTherapeutics Business Overview
7.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Major Product Offerings
7.6.4 Stealth BioTherapeutics Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.6.5 Stealth BioTherapeutics Key News
7.7 Gyroscope Therapeutics
7.7.1 Gyroscope Therapeutics Corporate Summary
7.7.2 Gyroscope Therapeutics Business Overview
7.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Major Product Offerings
7.7.4 Gyroscope Therapeutics Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.7.5 Gyroscope Therapeutics Key News
7.8 Regenerative Patch Technologies
7.8.1 Regenerative Patch Technologies Corporate Summary
7.8.2 Regenerative Patch Technologies Business Overview
7.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Major Product Offerings
7.8.4 Regenerative Patch Technologies Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.8.5 Regenerative Patch Technologies Key News
7.9 Roche Holding AG
7.9.1 Roche Holding AG Corporate Summary
7.9.2 Roche Holding AG Business Overview
7.9.3 Roche Holding AG Geographic Atrophy Treatment Major Product Offerings
7.9.4 Roche Holding AG Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.9.5 Roche Holding AG Key News
7.10 Gensight Biologics SA
7.10.1 Gensight Biologics SA Corporate Summary
7.10.2 Gensight Biologics SA Business Overview
7.10.3 Gensight Biologics SA Geographic Atrophy Treatment Major Product Offerings
7.10.4 Gensight Biologics SA Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.10.5 Gensight Biologics SA Key News
7.11 NGM Biopharmaceuticals
7.11.1 NGM Biopharmaceuticals Corporate Summary
7.11.2 NGM Biopharmaceuticals Business Overview
7.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Major Product Offerings
7.11.4 NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.11.5 NGM Biopharmaceuticals Key News
7.12 AstraZeneca
7.12.1 AstraZeneca Corporate Summary
7.12.2 AstraZeneca Business Overview
7.12.3 AstraZeneca Geographic Atrophy Treatment Major Product Offerings
7.12.4 AstraZeneca Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.12.5 AstraZeneca Key News
7.13 Lineage Cell Therapeutics
7.13.1 Lineage Cell Therapeutics Corporate Summary
7.13.2 Lineage Cell Therapeutics Business Overview
7.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Major Product Offerings
7.13.4 Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.13.5 Lineage Cell Therapeutics Key News
7.14 Allergan
7.14.1 Allergan Corporate Summary
7.14.2 Allergan Business Overview
7.14.3 Allergan Geographic Atrophy Treatment Major Product Offerings
7.14.4 Allergan Geographic Atrophy Treatment Revenue in Global Market (2017-2022)
7.14.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Geographic Atrophy Treatment Market Opportunities & Trends in Global Market
Table 2. Geographic Atrophy Treatment Market Drivers in Global Market
Table 3. Geographic Atrophy Treatment Market Restraints in Global Market
Table 4. Key Players of Geographic Atrophy Treatment in Global Market
Table 5. Top Geographic Atrophy Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Geographic Atrophy Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Geographic Atrophy Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Geographic Atrophy Treatment Product Type
Table 9. List of Global Tier 1 Geographic Atrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Geographic Atrophy Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Geographic Atrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Geographic Atrophy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Geographic Atrophy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Geographic Atrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Geographic Atrophy Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Geographic Atrophy Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Geographic Atrophy Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Geographic Atrophy Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Geographic Atrophy Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Geographic Atrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Geographic Atrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Geographic Atrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Geographic Atrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Geographic Atrophy Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Apellis Pharmaceuticals Corporate Summary
Table 31. Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offerings
Table 32. Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 33. IVERIC bio Corporate Summary
Table 34. IVERIC bio Geographic Atrophy Treatment Product Offerings
Table 35. IVERIC bio Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Alkeus Pharmaceuticals Corporate Summary
Table 37. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offerings
Table 38. Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Hemera Biosciences Corporate Summary
Table 40. Hemera Biosciences Geographic Atrophy Treatment Product Offerings
Table 41. Hemera Biosciences Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Allegro Ophthalmics Corporate Summary
Table 43. Allegro Ophthalmics Geographic Atrophy Treatment Product Offerings
Table 44. Allegro Ophthalmics Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Stealth BioTherapeutics Corporate Summary
Table 46. Stealth BioTherapeutics Geographic Atrophy Treatment Product Offerings
Table 47. Stealth BioTherapeutics Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Gyroscope Therapeutics Corporate Summary
Table 49. Gyroscope Therapeutics Geographic Atrophy Treatment Product Offerings
Table 50. Gyroscope Therapeutics Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Regenerative Patch Technologies Corporate Summary
Table 52. Regenerative Patch Technologies Geographic Atrophy Treatment Product Offerings
Table 53. Regenerative Patch Technologies Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Roche Holding AG Corporate Summary
Table 55. Roche Holding AG Geographic Atrophy Treatment Product Offerings
Table 56. Roche Holding AG Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Gensight Biologics SA Corporate Summary
Table 58. Gensight Biologics SA Geographic Atrophy Treatment Product Offerings
Table 59. Gensight Biologics SA Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 60. NGM Biopharmaceuticals Corporate Summary
Table 61. NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offerings
Table 62. NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Geographic Atrophy Treatment Product Offerings
Table 65. AstraZeneca Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Lineage Cell Therapeutics Corporate Summary
Table 67. Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offerings
Table 68. Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Allergan Corporate Summary
Table 70. Allergan Geographic Atrophy Treatment Product Offerings
Table 71. Allergan Geographic Atrophy Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Geographic Atrophy Treatment Segment by Type in 2021
Figure 2. Geographic Atrophy Treatment Segment by Application in 2021
Figure 3. Global Geographic Atrophy Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Geographic Atrophy Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Geographic Atrophy Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2021
Figure 8. By Type - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 12. US Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 24. China Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Geographic Atrophy Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Geographic Atrophy Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. IVERIC bio Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hemera Biosciences Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allegro Ophthalmics Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Stealth BioTherapeutics Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Gyroscope Therapeutics Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Regenerative Patch Technologies Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Holding AG Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gensight Biologics SA Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AstraZeneca Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Allergan Geographic Atrophy Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount